ghk-cu pdf (100 MG) GHK-Cu Copper Peptide Skincare Protocol

Early in the 21st century, GHR is considered to exhibit a negative effect on the process of mitochondrial biogenesis in vivo

doi: 10.3389/fnagi.2010.00032, 111 WardN.PaulE.WatsonP.CookeG

Adverse Reactions/Side Effects The following clinically significant adverse drug reactions are described elsewhere in the labeling: Drugs with Same Active Ingredient [see Warnings and Precautions (5.1)] Hypocalcemia and Mineral Metabolism [see Warnings and Precautions (5.2)] Renal Impairment [see Warnings and Precautions (5.3)] Osteonecrosis of the Jaw [see Warnings and Precautions (5.4)] Atypical Fractures Including Femoral Fractures [see Warnings and Precautions (5.5)] Musculoskeletal Pain [see Warnings and Precautions (5.6)] Patients with Asthma [see Warnings and Precautions (5.7)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice

GHK-Cu has a long history of study and use

Moreover, differences in the glycosylation pattern of recombinant proteins, which are generated via a cellular engineering process, may lead to immunogenicity